Blood cancers

COVID-19 and chemo: UK advises less immunosuppressive treatment

Haematologists in the UK are quickly re-thinking their approach to treating immunocompromised patients during widespread community transmission of the COVID-19 infection. In correspondence published in the British Journal of Haematology, a team from Oxford warned of the urgent need to “consider the unique impact this [COVID-19] may have on haematology patients and the practical steps ...

Already a member?

Login to keep reading.

© 2021 the limbic